BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive LeukemiaMatthew S. Zabriskie, Thomas O’Hare, Johanna Estrada et al.|Cancer Cell|2014Cited by 366
A novel activating <i>JAK1</i> mutation in chronic eosinophilic leukemiaWilliam Shomali, Jason Gotlib, Alisa Damnernsawad et al.|Blood Advances|2021Cited by 20